Inhibrx Biosciences, Inc.
INBX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002007919
In the last 90 days, Inhibrx Biosciences, Inc. insiders filed 6 open-market purchases and 2 sales; 162 institutions reported holding it in 13F filings for Q2 2026, worth $1.36B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Inhibrx Biosciences, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 88
- −37 vs. Q1 2024
- Shares held
- 9.68M
- −28.6M (−74.7%) vs. Q1 2024
- Total value
- $137.9M
- −$1.20B (−89.7%) vs. Q1 2024
- New holders
- 17
- 11 more added
- Sold out
- 54
- 59 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 162 | $1.36B |
| Q1 2026 | 135 | $854.6M |
| Q4 2025 | 138 | $1.01B |
| Q3 2025 | 102 | $353.6M |
| Q2 2025 | 89 | $148.9M |
| Q1 2025 | 92 | $151.0M |
| Q4 2024 | 101 | $171.9M |
| Q3 2024 | 96 | $139.3M |
| Q2 2024 | 88 | $137.9M |
| Q1 2024 | 126 | $1.34B |
| Q4 2023 | 126 | $1.54B |
| Q3 2023 | 111 | $716.1M |
| Q2 2023 | 107 | $935.2M |
| Q1 2023 | 108 | $691.6M |
| Q4 2022 | 116 | $886.0M |
| Q3 2022 | 102 | $512.2M |
| Q2 2022 | 100 | $297.3M |
| Q1 2022 | 99 | $548.0M |
| Q4 2021 | 101 | $1.01B |
| Q3 2021 | 66 | $681.6M |
| Q2 2021 | 61 | $538.8M |
| Q1 2021 | 55 | $326.3M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Inhibrx Biosciences, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Swiss National Bank | 0 | $0 | 0.00% | −42,000−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −40,976−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −31,335−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −30,561−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −29,580−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −21,476−100.0% | Sold out |
| Alaethes Wealth LLC | 0 | $0 | 0.00% | −19,341−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −18,866−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −16,926−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −16,741−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −16,103−100.0% | Sold out |
| Black Maple Capital Management LP | 0 | $0 | 0.00% | −15,863−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −21,920−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −14,812−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −14,673−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −14,499−100.0% | Sold out |
| RS Crum Inc. | 0 | $0 | 0.00% | −14,119−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −13,466−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −11,370−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −11,346−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −10,982−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −10,218−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −9,683−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −9,544−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −9,458−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −9,106−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −8,240−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −8,143−100.0% | Sold out |
| GAM Holding AG | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| HCR Wealth Advisors | 0 | $0 | 0.00% | −6,300−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −5,848−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −3,143−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −2,910−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,950−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,215−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −942−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |